Does TRT for women really help build muscle? We checked

What did @unfilteredmenopause actually say?

Alice, a self-identified nurse practitioner, spent most of this video defusing fears about testosterone therapy in women. Her core pitch: "when it's done correctly testosterone isn't about becoming masculine, it's about becoming magnificent." She named the common anxieties — beard growth, bodybuilder physique, personality changes — and dismissed them as internet myth. Then she credited TRT with improving energy, mood, focus, and confidence in herself and her patients. The framing is reassuring, the tone is personal, and her credentials (NP, clinic owner) are front and center. What she did not do is discuss dosing thresholds, monitoring protocols, the difference between optimization and supraphysiologic levels, or the fact that testosterone therapy for women is not FDA-approved for most of the uses she's implying.

Does the science back this up?

Partly, yes. The evidence for testosterone in women is real but more limited than this video implies. A 2019 consensus statement from the Global Consensus Position Statement (Davis et al., 2019, Journal of Clinical Endocrinology and Metabolism) found evidence supporting testosterone use in postmenopausal women specifically for hypoactive sexual desire disorder. Mood and energy benefits are reported anecdotally and in some smaller trials, but the robust, long-term data simply isn't there yet. A 2023 review in Climacteric (Islam et al.) noted that while short-term studies show benefits for libido and some aspects of wellbeing, data on cardiovascular and breast cancer risk beyond two years remain insufficient. The "everything shifts" claim — covering energy, mood, focus, and confidence simultaneously — is a broader promise than the current evidence can reliably support for all women across the board.

What did they get wrong (or right)?

Credit where it's due: the beard and bodybuilder fears are genuinely overblown in popular culture. At physiologic female doses, significant virilization is uncommon, though not impossible. Alice is right to push back on that. She's also right that dose matters enormously, which is the implication of "when it's done correctly." But here's where the video cuts corners. That phrase — "done correctly" — is doing enormous work without any explanation of what correct actually means. Clitoral enlargement, acne, hair thinning, and voice changes are documented side effects even at therapeutic doses (Wierman et al., 2014, JCEM). The caption's joke about "beard shaving on Mondays" is presented as a harmless punchline, but virilization side effects are a real monitoring concern, not just an internet rumor to laugh off. Framing them purely as comedy undersells an informed-consent conversation that patients deserve.

What should you actually know?

Testosterone therapy for women exists in a complicated regulatory space. No testosterone product is currently FDA-approved specifically for use in women in the United States, which means any prescribing happens off-label. That doesn't make it wrong — off-label prescribing is common and legal — but it means the burden on the clinician to monitor and individualize care is higher, not lower. Free and total testosterone levels, SHBG, hematocrit, and symptom tracking should all be part of ongoing care. The Global Consensus (Davis et al., 2019) specifically recommends against using supraphysiologic doses and recommends monitoring to keep levels within the normal female range. If a telehealth platform or clinic is optimizing your hormones without regular bloodwork, that is a red flag regardless of how empowering the branding is. Alice's message that low testosterone can affect wellbeing in women is legitimate. The missing piece is that legitimate care requires more than a confident elevator pitch.